Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

1.

Genomic Classification of Cutaneous Melanoma.

Cancer Genome Atlas Network. Electronic address: irwatson@mdanderson.org; Cancer Genome Atlas Network.

Cell. 2015 Jun 18;161(7):1681-96. doi: 10.1016/j.cell.2015.05.044.

PMID:
26091043
2.

Comprehensive genomic characterization of head and neck squamous cell carcinomas.

Cancer Genome Atlas Network.

Nature. 2015 Jan 29;517(7536):576-82. doi: 10.1038/nature14129.

3.

Characterization of HPV and host genome interactions in primary head and neck cancers.

Parfenov M, Pedamallu CS, Gehlenborg N, Freeman SS, Danilova L, Bristow CA, Lee S, Hadjipanayis AG, Ivanova EV, Wilkerson MD, Protopopov A, Yang L, Seth S, Song X, Tang J, Ren X, Zhang J, Pantazi A, Santoso N, Xu AW, Mahadeshwar H, Wheeler DA, Haddad RI, Jung J, Ojesina AI, Issaeva N, Yarbrough WG, Hayes DN, Grandis JR, El-Naggar AK, Meyerson M, Park PJ, Chin L, Seidman JG, Hammerman PS, Kucherlapati R; Cancer Genome Atlas Network.

Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15544-9. doi: 10.1073/pnas.1416074111. Epub 2014 Oct 13.

4.

Comprehensive molecular profiling of lung adenocarcinoma.

Cancer Genome Atlas Research Network.

Nature. 2014 Jul 31;511(7511):543-50. doi: 10.1038/nature13385. Epub 2014 Jul 9. Erratum in: Nature. 2014 Oct 9;514(7521):262. Rogers, K [corrected to Rodgers, K].

5.

Comprehensive molecular characterization of urothelial bladder carcinoma.

Cancer Genome Atlas Research Network.

Nature. 2014 Mar 20;507(7492):315-22. doi: 10.1038/nature12965. Epub 2014 Jan 29.

6.

Comprehensive molecular portraits of human breast tumours.

Cancer Genome Atlas Network.

Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.

7.

Seroquel: biochemical profile of a potential atypical antipsychotic.

Saller CF, Salama AI.

Psychopharmacology (Berl). 1993;112(2-3):285-92.

PMID:
7871032
8.

Clozapine and haloperidol have differential effects on glutamic acid decarboxylase mRNA in the pallidal nuclei of the rat.

Mercugliano M, Saller CF, Salama AI, U'Prichard DC, Chesselet MF.

Neuropsychopharmacology. 1992 May;6(3):179-87.

PMID:
1599608
9.

Glucose concentrations in brain and blood: regulation by dopamine receptor subtypes.

Saller CF, Kreamer LD.

Brain Res. 1991 Apr 19;546(2):235-40.

PMID:
1829974
10.

5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade.

Saller CF, Czupryna MJ, Salama AI.

J Pharmacol Exp Ther. 1990 Jun;253(3):1162-70.

PMID:
2141636
11.

Acute treatment with clozapine blocks D1 dopamine receptor binding in discrete brain areas of the male rat.

Fuxe K, von Euler G, Agnati LF, Saller CF, Salama A, Goldstein M.

Neurosci Lett. 1989 Nov 20;106(1-2):169-74.

PMID:
2531306
13.

Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).

Saller CF, Kreamer LD, Adamovage LA, Salama AI.

Life Sci. 1989;45(10):917-29.

PMID:
2529407
14.

3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.

Saller CF, Salama AI.

Naunyn Schmiedebergs Arch Pharmacol. 1986 Oct;334(2):125-32.

PMID:
2878374
15.

D-1 dopamine receptor stimulation elevates plasma prolactin levels.

Saller CF, Salama AI.

Eur J Pharmacol. 1986 Mar 11;122(1):139-42.

PMID:
3007174
16.

D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.

Saller CF, Salama AI.

J Pharmacol Exp Ther. 1986 Mar;236(3):714-20.

PMID:
3005552
17.

Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.

Saller CF, Salama AI.

Eur J Pharmacol. 1986 Feb 18;121(2):181-8.

PMID:
3699091
18.

Functional interactive effects of D1 and D2 dopamine receptor blockade.

Salama AI, Saller CF.

Adv Exp Med Biol. 1986;204:137-50. No abstract available.

PMID:
2947425
19.

Homocysteine prevents apomorphine-induced decreases in dopamine metabolites.

Saller CF, Salama AI.

Brain Res. 1985 Dec 23;360(1-2):407-8.

PMID:
4075182
20.

Modulation of dopamine receptor supersensitivity by chronic insulin: implication in schizophrenia.

Lozovsky DB, Kopin IJ, Saller CF.

Brain Res. 1985 Sep 16;343(1):190-3.

PMID:
3899277
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk